Clinical Trial Update: Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This document announces a Phase 1 study of NMS-03305293 for adults with relapsed small cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• NMS-03305293

Snippet

Sponsor: Nerviano Medical Sciences | Conditions: Small Cell Lung Cancer | Phase 1 | Status: RECRUITING